GSK Statistics
Total Valuation
GSK plc has a market cap or net worth of $80.24 billion. The enterprise value is $97.90 billion.
| Market Cap | 80.24B |
| Enterprise Value | 97.90B |
Important Dates
The next confirmed earnings date is Wednesday, July 31, 2024, before market open.
| Earnings Date | Jul 31, 2024 |
| Ex-Dividend Date | May 16, 2024 |
Share Statistics
GSK plc has 2.04 billion shares outstanding.
| Shares Outstanding | 2.04B |
| Owned by Insiders (%) | 0.06% |
| Owned by Institutions (%) | 15.29% |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 13.90 and the forward PE ratio is 10.32. GSK plc's PEG ratio is 1.09.
| PE Ratio | 13.90 |
| Forward PE | 10.32 |
| PS Ratio | 2.04 |
| Forward PS | 2.43 |
| PB Ratio | 4.49 |
| P/FCF Ratio | 9.76 |
| PEG Ratio | 1.09 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.85, with an EV/FCF ratio of 11.91.
| EV / Earnings | 17.03 |
| EV / Sales | 2.48 |
| EV / EBITDA | 12.85 |
| EV / EBIT | 12.65 |
| EV / FCF | 11.91 |
Financial Position
The company has a current ratio of 0.87, with a Debt / Equity ratio of 1.28.
| Current Ratio | 0.87 |
| Quick Ratio | 0.55 |
| Debt / Equity | 1.28 |
| Debt / EBITDA | 3.01 |
| Debt / FCF | 2.79 |
| Interest Coverage | 7.94 |
Financial Efficiency
Return on equity (ROE) is 33.80% and return on invested capital (ROIC) is 16.66%.
| Return on Equity (ROE) | 33.80% |
| Return on Assets (ROA) | 7.50% |
| Return on Capital (ROIC) | 16.66% |
| Revenue Per Employee | $561,304 |
| Profits Per Employee | $81,877 |
| Employee Count | 70,212 |
| Asset Turnover | 0.52 |
| Inventory Turnover | 1.55 |
Taxes
In the past 12 months, GSK plc has paid $973.67 million in taxes.
| Income Tax | 973.67M |
| Effective Tax Rate | 14.48% |
Stock Price Statistics
The stock price has increased by +11.82% in the last 52 weeks. The beta is 0.30, so GSK plc's price volatility has been lower than the market average.
| Beta (5Y) | 0.30 |
| 52-Week Price Change | +11.82% |
| 50-Day Moving Average | 41.57 |
| 200-Day Moving Average | 39.68 |
| Relative Strength Index (RSI) | 45.54 |
| Average Volume (20 Days) | 3,438,467 |
Short Selling Information
| Short Interest | 13.22M |
| Short Previous Month | 7.94M |
| Short % of Shares Out | 0.72% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 3.14 |
Income Statement
In the last 12 months, GSK plc had revenue of $39.41 billion and earned $5.75 billion in profits. Earnings per share was $2.82.
| Revenue | 39.41B |
| Gross Profit | 28.60B |
| Operating Income | 7.95B |
| Pretax Income | 6.76B |
| Net Income | 5.75B |
| EBITDA | 7.62B |
| EBIT | 7.74B |
| Earnings Per Share (EPS) | $2.82 |
Balance Sheet
The company has $5.29 billion in cash and $22.95 billion in debt, giving a net cash position of -$17.66 billion or -$8.66 per share.
| Cash & Cash Equivalents | 5.29B |
| Total Debt | 22.95B |
| Net Cash | -17.66B |
| Net Cash Per Share | -$8.66 |
| Equity (Book Value) | 17.87B |
| Book Value Per Share | 8.76 |
| Working Capital | -3.41B |
Cash Flow
In the last 12 months, operating cash flow was $9.91 billion and capital expenditures -$1.69 billion, giving a free cash flow of $8.22 billion.
| Operating Cash Flow | 9.91B |
| Capital Expenditures | -1.69B |
| Free Cash Flow | 8.22B |
| FCF Per Share | $4.05 |
Margins
Gross margin is 72.57%, with operating and profit margins of 20.16% and 14.59%.
| Gross Margin | 72.57% |
| Operating Margin | 20.16% |
| Pretax Margin | 17.16% |
| Profit Margin | 14.59% |
| EBITDA Margin | 19.34% |
| EBIT Margin | 19.64% |
| FCF Margin | 20.86% |
Dividends & Yields
This stock pays an annual dividend of $1.54, which amounts to a dividend yield of 3.91%.
| Dividend Per Share | $1.54 |
| Dividend Yield | 3.91% |
| Dividend Growth (YoY) | 8.30% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 54.51% |
| Buyback Yield | 0.93% |
| Shareholder Yield | 4.83% |
| Earnings Yield | 7.16% |
| FCF Yield | 10.25% |
Analyst Forecast
The average price target for GSK plc is $48.00, which is 21.98% higher than the current price. The consensus rating is "Buy".
| Price Target | $48.00 |
| Price Target Difference | 21.98% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 5.18% |
| EPS Growth Forecast (5Y) | -1.10% |
Stock Splits
The last stock split was on July 22, 2022. It was a forward split with a ratio of 1226:1000.
| Last Split Date | Jul 22, 2022 |
| Split Type | Forward |
| Split Ratio | 1226:1000 |
Scores
GSK plc has an Altman Z-Score of 1.82 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.82 |
| Piotroski F-Score | 7 |